In a Chinese study from Liu et al. of 154 adult patients aged 18–65 years with FLT3-ITD-mutated AML, non-JMD ITDs, particularly within the β1-sheet of the TKD1, were associated with overall worse RFS at six months and OS at three years. This evidence concerns the gene FLT3 and acute myeloid leukemia.